150 related articles for article (PubMed ID: 24419536)
1. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
Piezzi V; Kullak-Ublick GA; Glisenti P
Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G
J Am Geriatr Soc; 2015 Jan; 63(1):179-80. PubMed ID: 25597570
[No Abstract] [Full Text] [Related]
6. [Hypomagnesemia induced by proton pump inhibitors, diarrhea, and lactose intolerance].
Cano Megías M; Alvarez Santirso R; Iglesias Lozano P; Carrasco De La Fuente M; Pérez López G
Endocrinol Nutr; 2011 Dec; 58(10):550-4. PubMed ID: 21764396
[No Abstract] [Full Text] [Related]
7. Severe hypomagnesemia and hypoparathyroidism induced by omeprazole.
Rodríguez Ortega P; Rebollo Pérez I; Laínez López M; Roldán Mayorga E; Hernández Lavado R; Creagh Cerquera R
Endocrinol Nutr; 2013 Mar; 60(3):156-7. PubMed ID: 22627012
[No Abstract] [Full Text] [Related]
8. In brief: PPI's and hypomagnesemia.
Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
[No Abstract] [Full Text] [Related]
9. [Drugs affecting serum magnesium concentration].
Kawamura Y
Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
[TBL] [Abstract][Full Text] [Related]
10. [Review: UPDATE on magnesium metabolism].
Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
[TBL] [Abstract][Full Text] [Related]
11. Recent safety concerns with proton pump inhibitors.
Chen J; Yuan YC; Leontiadis GI; Howden CW
J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
[TBL] [Abstract][Full Text] [Related]
12. Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab.
Kimura M; Usami E; Teramachi H; Yoshimura T
Cancer Chemother Pharmacol; 2020 Sep; 86(3):383-391. PubMed ID: 32789758
[TBL] [Abstract][Full Text] [Related]
13. [The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone].
Yamamoto Y; Watanabe K; Matsushita H; Tsukiyama I; Matsuura K; Wakatsuki A
Yakugaku Zasshi; 2017; 137(1):79-82. PubMed ID: 28049899
[TBL] [Abstract][Full Text] [Related]
14. Isolated hypomagnesemia in a patient treated with capecitabine.
Rajapakse S; Rodrigo C; Rajapakse AC
J Oncol Pharm Pract; 2013 Sep; 19(3):254-6. PubMed ID: 22948887
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study.
Schulz C; Heinemann V; Heinrich K; Haas M; Holch JW; Fraccaroli A; Held S; von Einem JC; Modest DP; Fischer von Weikersthal L; Kullmann F; Moehler M; Scheithauer W; Jung A; Stintzing S
Anticancer Drugs; 2020 Sep; 31(8):856-865. PubMed ID: 32639280
[TBL] [Abstract][Full Text] [Related]
16. Severe hypomagnesemia and electrolyte disturbances induced by proton pump inhibitors.
Turnock M; Pagnoux C; Shore K
J Dig Dis; 2014 Aug; 15(8):459-62. PubMed ID: 24798177
[No Abstract] [Full Text] [Related]
17. [Emergent adverse effects of proton pump inhibitors].
Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
[TBL] [Abstract][Full Text] [Related]
18. [Familial hypomagnesemia, hypercalciuria with nephrocalcinosis syndrome: report of a case].
Alvarez Ponte SB; López M; Golinelli F; D'Angelo S; Martin S
Arch Argent Pediatr; 2011 Feb; 109(1):8-12. PubMed ID: 21283935
[TBL] [Abstract][Full Text] [Related]
19. Claudin 19-based familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a sibling pair.
Sharma S; Place E; Lord K; Leroy BP; Falk MJ; Pradhan M
Clin Nephrol; 2016 Jun; 85(6):346-52. PubMed ID: 27007868
[TBL] [Abstract][Full Text] [Related]
20. Increasing interest strategies to appropriately measure of serum magnesium: An opportunity for clinical laboratories to further unmask hypomagnesemia.
Salinas M; Flores E; López-Garrigós M; Puche C; Leiva-Salinas C
Clin Biochem; 2021 Jun; 92():90. PubMed ID: 33831388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
